Page last updated: 2024-11-05

zolpidem and Delusional Disorder

zolpidem has been researched along with Delusional Disorder in 1 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Delusional Disorder: Disorder with presentation of a facade of coldness with characteristic pervasive mistrust and suspiciousness of others.

Research Excerpts

ExcerptRelevanceReference
"There is no consensus regarding treatment of catatonia and the main recent therapeutic progress has been the development of the zolpidem diagnostic and therapeutic test."7.81Zolpidem test and catatonia. ( Cottencin, O; Javelot, H; Javelot, T; Michel, B; Steiner, R, 2015)
"There is no consensus regarding treatment of catatonia and the main recent therapeutic progress has been the development of the zolpidem diagnostic and therapeutic test."3.81Zolpidem test and catatonia. ( Cottencin, O; Javelot, H; Javelot, T; Michel, B; Steiner, R, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Javelot, H1
Michel, B1
Steiner, R1
Javelot, T1
Cottencin, O1

Other Studies

1 other study available for zolpidem and Delusional Disorder

ArticleYear
Zolpidem test and catatonia.
    Journal of clinical pharmacy and therapeutics, 2015, Volume: 40, Issue:6

    Topics: Adult; Antipsychotic Agents; Catatonia; Humans; Male; Pyridines; Schizophrenia, Paranoid; Zolpidem

2015